The Latest Breaking News from Spectrum Pharmaceuticals

12 Health Care Stocks Moving In Tuesday's Intraday Session

 

Benzinga · Sep 20, 2022

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

Benzinga · Sep 9, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Benzinga · Jun 21, 2022

Spectrum Pharmaceuticals: Q4 Earnings Insights

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · Mar 17, 2022

A Preview Of Spectrum Pharmaceuticals's Earnings

Spectrum Pharmaceuticals (NASDAQ:SPPI) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate that Spectrum Pharmaceuticals will report an earnings per share (EPS) of $-0.21.

Benzinga · Mar 16, 2022